PIRS: Pieris Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 19.15
Enterprise Value ($M) -13.75
Book Value ($M) 30.51
Book Value / Share 0.31
Price / Book 0.63
NCAV ($M) 30.22
NCAV / Share 0.31
Price / NCAV 0.63

Profitability (mra)
Return on Invested Capital (ROIC) -0.66
Return on Assets (ROA) -0.29
Return on Equity (ROE) -1.00

Liquidity (mrq)
Quick Ratio 2.05
Current Ratio 2.05

Balance Sheet (mrq) ($M)
Current Assets 59.09
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Checkpoint Capital L.P. 0.00 -100.00
02-14 13G/A Aquilo Capital Management, LLC 1.10 -80.16
02-14 13G/A Lynx1 Capital Management LP 9.90 73.68
02-02 13G/A Soleus Capital Master Fund, L.P. 0.00 -100.00
08-17 13D/A Biotechnology Value Fund L P 20.80 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 87,809 368,760 23.81
2024-03-27 105,217 792,387 13.28
2024-03-26 12,649 358,787 3.53
2024-03-25 111,747 2,968,260 3.76

(click for more detail)

Similar Companies
PCSA – Processa Pharmaceuticals, Inc. PDSB – PDS Biotechnology Corporation
PHIO – Phio Pharmaceuticals Corp. PLUR – Pluri Inc.
PMCB – PharmaCyte Biotech, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Pieris Pharmaceuticals